Basel, Switzerland

Roland Beckmann

This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Beckmann. Retrieved from https://idiyas.com/inventor/roland-beckmann-leczfec0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roland Beckmann: Innovator in Antibody Development

Introduction

Roland Beckmann is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents to his name, Beckmann's work has the potential to impact various therapeutic applications.

Latest Patents

Beckmann's latest patents include innovative solutions such as an antibody that binds to VEGF and IL-1beta, along with methods of use. Another significant patent involves an antibody that binds to VEGF-A and ANG2, also accompanied by methods of use. These patents reflect his commitment to advancing medical science through targeted therapies.

Career Highlights

Currently, Roland Beckmann is employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Beckmann has worked alongside talented colleagues such as Joerg Moelleken and Guido Hartmann. Their combined expertise fosters an environment of innovation and creativity, driving forward the development of new therapeutic solutions.

Conclusion

In summary, Roland Beckmann is a distinguished inventor whose work in antibody development is paving the way for advancements in medical treatments. His contributions are vital to the ongoing evolution of biotechnology and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…